Alfred Hospital, Melbourne
Reports from Australia, the United States and Austria add new data to hepatitis C virus research
Published in Hospital Business Week, August 6th, 2006
Study 1: According to recently published research from Australia, hepatitis C virus (HCV) treatment can achieve sustained virological response (SVR).
"International controlled trials have demonstrated increasing SVR rates to interferon-based therapies in hepatitis-C-treated patients. Response rates of 6-20% in the era of interferon monotherapy are compared with 42-82% with pegylated interferon plus ribavirin.
"The virological durability of the SVR is unknown and the optimal follow-up for these patients is unclear. The aim of our study...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Bioenvision
New survival data on Evoltra (clofarabine) in elderly leukemia patients reported - DanioLabs
DanioLabs starts clinical trial with new treatments for Parkinson disease symptoms - European Journal of Nutrition
Soy germ isoflavones in high dose supplement shown to reduce bone loss in postmenopausal women - Fred Hutchinson Cancer Research Center, Seattle
Reports from the United States and United Kingdom add new data to breast cancer research - Kemin Pharma
Kemin targets Clostridium difficile, an acute and severe hospital infection - LanVision Systems
Dopamine drug leads to recovery of function in rat model of Parkinson disease - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
